Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 18 Prostatic Neoplasms 16 Colorectal Neoplasms 14 Neoplasms 12 Hematopoietic and Lymphatic System Neoplasm 12 Lung Neoplasms 9 Hematologic Neoplasms 8 Ovarian Neoplasms 5 Multiple Myeloma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Malignant Solid Neoplasm 4 Lymphoma 4 Urinary Bladder Neoplasms 3 Hematopoietic and Lymphoid System Neoplasm 3 Advanced Malignant Solid Neoplasm 3 Triple Negative Breast Neoplasms 2 Thyroid Cancer, Papillary 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Obesity-Related Malignant Neoplasm 2 Mouth Neoplasms 2 Motor Activity 2 Melanoma 2 Malignant Female Reproductive System Neoplasm 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Genetic Predisposition to Disease 2

Interventions

Cisplatin 5 pembrolizumab 4 Surveys and Questionnaires 2 Radiotherapy 2 N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2 Fluorouracil 2 Docetaxel 2 Cetuximab 2 niraparib 1 monalizumab 1 durvalumab 1 dostarlimab 1 Tablets 1 Surgical Flaps 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 LY2940680 1 Interviews as Topic 1 Combined Modality Therapy 1 Chemical Fractionation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Laryngeal Diseases × Interviews as Topic × 1 year × Clear all

NCT01647477 2026-03-13

DEREDIA

Centre Oscar Lambret

Phase NA Terminated

Laryngeal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡